Dear colleagues, community members, and friends,
The other day as I was taking a break outside of my office, a group of antique car collectors cruised through our campus to honk their horns and wave signs in recognition of the Star City's front-line workers.
One of them asked me if I knew where "those folks doing the COVID-19 testing" were, so he could thank them personally. I gestured behind me to the Fralin Biomedical Research Institute at VTC, where we set up a new high-throughput testing lab last month, and explained that a second Virginia Tech COVID-19 testing lab is in Blacksburg. The gentleman asked me to say "thank you" to our team, and I was proud and happy to relay the message.
As biomedical scientists, we aren't called to this profession because we seek recognition. We choose this work because we want to better understand the processes of life and apply that understanding to improve human health. This recent small exchange with a stranger, in the context of one of the world’s great health challenges, exemplifies the impact of science and its benefits to humankind.
In addition to our researchers who have dedicated countless hours to develop and operate our new COVID-19 testing operations, several of our faculty have developed new approaches and submitted grant funding applications based on these approaches to study the pathogenesis of the SARS-CoV-2 virus more closely, and identify new therapeutic approaches to prevent or limit its sometimes devastating effects. There is still a lot that we don't understand about how this new coronavirus works, and our team is eager to use their expertise in genetics, virology, neuroscience, and cardiovascular science to join the international effort to help develop novel diagnostics, therapeutics, and preventions.
I want to thank every member of the Fralin Biomedical Research Institute team for their dedication, perseverance, and ingenuity. We will continue to work diligently to confront the pandemic, serve our world, and ensure a safe and bright future for all.
In the spirit of Ut Prosim,
Mike Friedlander, Ph.D.
Executive Director, Fralin Biomedical Research Institute at VTC
Vice President for Health Sciences and Technology, Virginia Tech
|